Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$7.9 - $10.22 $1.33 Million - $1.72 Million
-168,700 Closed
0 $0
Q2 2022

Aug 14, 2023

BUY
$4.82 - $7.7 $813,134 - $1.3 Million
168,700 New
168,700 $894,000
Q1 2022

May 12, 2023

BUY
$6.0 - $16.98 $1.01 Million - $2.86 Million
168,700 New
168,700 $1.1 Million
Q1 2022

May 09, 2022

SELL
$6.0 - $16.98 $1.01 Million - $2.86 Million
-168,700 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$15.19 - $29.33 $2.56 Million - $4.95 Million
168,700 New
168,700 $2.77 Million
Q3 2021

Nov 14, 2022

BUY
$27.35 - $37.28 $1.21 Million - $1.65 Million
44,191 New
44,191 $1.28 Million
Q3 2021

Nov 05, 2021

SELL
$27.35 - $37.28 $1.21 Million - $1.65 Million
-44,191 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$26.5 - $38.23 $1.17 Million - $1.69 Million
44,191 New
44,191 $1.53 Million
Q2 2021

Aug 10, 2021

SELL
$26.5 - $38.23 $1.46 Million - $2.1 Million
-55,056 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$29.83 - $56.81 $1.64 Million - $3.13 Million
55,056 New
55,056 $1.74 Million
Q1 2021

May 07, 2021

SELL
$29.83 - $56.81 $3.5 Million - $6.66 Million
-117,255 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$39.12 - $54.99 $4.59 Million - $6.45 Million
117,255 New
117,255 $5.54 Million
Q4 2020

Feb 10, 2021

SELL
$39.12 - $54.99 $6.09 Million - $8.56 Million
-155,716 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$29.21 - $46.58 $4.55 Million - $7.25 Million
155,716 New
155,716 $7.25 Million
Q3 2020

Nov 10, 2020

SELL
$29.21 - $46.58 $4.32 Million - $6.89 Million
-147,914 Closed
0 $0
Q2 2020

Aug 13, 2021

BUY
$33.67 - $40.0 $4.98 Million - $5.92 Million
147,914 New
147,914 $5.34 Million
Q2 2020

Aug 07, 2020

SELL
$33.67 - $40.0 $1.19 Million - $1.41 Million
-35,292 Closed
0 $0
Q1 2020

May 07, 2021

BUY
$24.28 - $49.8 $856,889 - $1.76 Million
35,292 New
35,292 $1.25 Million
Q1 2020

May 08, 2020

SELL
$24.28 - $49.8 $371,289 - $761,541
-15,292 Closed
0 $0
Q4 2019

Mar 03, 2020

BUY
$24.84 - $45.46 $379,853 - $695,174
15,292 New
15,292 $695,000
Q2 2018

Jul 23, 2018

SELL
$11.13 - $21.86 $195,888 - $384,736
-17,600 Closed
0 $0
Q1 2018

May 15, 2019

BUY
$7.93 - $13.41 $139,568 - $236,016
17,600 New
17,600 $212,000
Q1 2018

May 09, 2018

SELL
$7.93 - $13.41 $198,250 - $335,250
-25,000 Closed
0 $0
Q4 2017

Mar 05, 2018

BUY
$6.87 - $9.19 $171,750 - $229,750
25,000 New
25,000 $190,000
Q4 2017

Feb 09, 2018

SELL
$6.87 - $9.19 $171,750 - $229,750
-25,000 Closed
0 $0
Q3 2017

Nov 13, 2018

BUY
$6.48 - $8.73 $162,000 - $218,250
25,000 New
25,000 $200,000
Q3 2017

Nov 07, 2017

SELL
$6.48 - $8.73 $162,000 - $218,250
-25,000 Closed
0 $0
Q2 2017

Jul 24, 2018

BUY
N/A
25,000
25,000 $209,000

Others Institutions Holding ZYME

About Zymeworks Inc.


  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $872M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.